Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between the north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
Carter M.J., Lobo A.J., and Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl 5 (2004) V1-V16
Stange E.F., Schreiber S., Fölsch U.R., von Herbay A., Schölmerich J., Hoffmann J., et al. Diagnostik und Therapie des M. Crohn-Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 41 (2003) 19-68
Travis S.P., Stange E.F., Lémann M., Oresland T., Chowers Y., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut Suppl 1 (Mar 2006) i16-i35
Stange E.F., Travis S.P., Vermeire S., Beglinger C., Kupcinkas L., Geboes K., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55 Suppl 1 (2006) i1-i15
Fink A., Kosecoff J., Chassin M., and Brook R.H. Consensus methods: characteristics and guidelines for use. Am J Public Health 74 (1984) 979-983
Anonymous, Centre for Evidence Based Medicine, Oxford. Levels of evidence and grades of recommendation. http://www.cebm.net/levels_of_evidence.asp.
Su C., Lichtenstein G.R., Krok K., Brensinger C.M., and Lewis J.D. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology 126 (2004) 1257-1269
Irvine E.J. Assessing outcomes in clinical trials. In: Satsangi J., and Sutherland L.R. (Eds). Inflammatory bowel diseases (2003), Churchill Livingstone, London 319-333
Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Löfberg R., Modigliani R., et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122 (2002) 512-530
Brignola C., Campieri M., Bazzocchi G., Farruggia P., Tragnone A., and Lanfranchi G.A. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 91 (1986) 1490-1494
Brignola C., Iannone P., Pasquali S., Campieri M., Gionchetti P., Belluzzi A., et al. Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease. Dig Dis Sci 37 (1992) 29-32
Rutgeerts P., D'Haens G., Targan S., Vasiliauskas E., Hanauer S.B., Present D.H., et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 117 (1999) 761-769
Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., and Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99 (1990) 956-963
Caprilli R., Andreoli A., Capurso L., Corrao G., D'Albasio G., Gioieni A., et al., Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of CD. Aliment Pharmacol Ther 8 (1994) 35-43
Simrén M., Axelsson J., Gillberg, Abrahamsson H., Svedlund J., and Björnsson E.S. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97 (2002) 389-396
Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126 6 (2004) 1504-1517
Sands B.E. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 126 6 (2004) 1518-1532
American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999;116(6):1461-3.
Burgmann T., Clara I., Graff L., Walker J., Lix L., Rawsthorne P., et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis-how much is irritable bowel syndrome?. Clin Gastroenterol Hepatol 4 5 (2006) 614-620
Pimentel M., Chang M., Chow E.J., Tabibzadeh S., Kirit-Kiriak V., Targan S.R., et al. Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Am J Gastroenterol 95 12 (2000) 3458-3462
Lennard-Jones J.E., and Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 9 4 (1997) 353-359
Farmer R.G., Hawk W.A., and Turnbull Jr. R.B. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 68 4 Pt 1 (1975) 627-635
Schwartz D.A., Loftus Jr. E.V., Tremaine W.J., Panaccione R., Harmsen W.S., Zinsmeister A.R., et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122 4 (2002) 875-880
Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
Price A.B. Overlap in the spectrum of non-specific inflammatory bowel disease-'colitis indeterminate'. J Clin Pathol 31 6 (1978) 567-577
Andersson R.E., Olaison G., Tysk C., and Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124 1 (2003) 40-46
Bridger S., Lee J.C., Bjarnason I., Jones J.E., and Macpherson A.J. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 51 1 (2002) 21-25
Garcia Rodriguez L.A., Ruigomez A., and Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130 6 (2006) 1588-1594
Reinisch W., Miehsler W., Dejaco C., Harrer M., Waldhoer T., Lichtenberger C., et al. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther 17 11 (2003) 1371-1380
Fagan E.A., Dyck R.F., Maton P.N., Hodgson H.J., Chadwick V.S., Petrie A., et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 12 4 (1982) 351-359
Poullis A.P., Zar S., Sundaram K.K., Moodie S.J., Risley P., Theodossi A., et al. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol 14 4 (2002) 409-412
Vermeire S., Van Assche G., and Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10 5 (2004) 661-665
Sachar D.B., Luppescu N.E., Bodian C., Shlien R.D., Fabry T.L., and Gumaste V.V. Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 12 6 (1990) 643-646
D'Inca R., Dal P.E., Di L.V., et al. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis 22 4 (2007) 429-437
Gaya D.R., Lyon T.D., Duncan A., Neilly J.B., Han S., Howell J., et al. Faecal calprotectin in the assessment of Crohn's disease activity. QJM 98 6 (2005) 435-441
Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., Bridger S., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 47 4 (2000) 506-513
Tibble J.A., Sigthorsson G., Bridger S., Fagerhol M.K., and Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119 1 (2000) 15-22
Kane S.V., Sandborn W.J., Rufo P.A., Zholudev A., Boone J., Lyerly D., et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 98 6 (2003) 1309-1314
de Jong N.S., Leach S.T., and Day A.S. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm Bowel Dis 12 7 (2006) 566-572
Kaiser T., Langhorst J., Wittkowski H., Becker K., Friedrich A.W., Rueffer A., et al. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56 12 (2007) 1706-1713
Mylonaki M., Langmead L., Pantes A., Johnson F., and Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 16 8 (2004) 775-778
Reese G.E., Constantinides V.A., Simillis C., Darzi A.W., Orchard T.R., Fazio V.W., et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 101 10 (2006) 2410-2422
Dubinsky M.C., Kugathasan S., Mei L., Picorjnell Y., Nebel J., Wrobel I., et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 6 10 (2008) 1105-1111
Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 10 (2007) 1394-1403
Vermeire S., Van Assche G., and Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55 3 (2006) 426-431
Coremans G., Rutgeerts P., Geboes K., Van den Oord J., Ponette E., and Vantrappen G. The value of ileoscopy with biopsy in the diagnosis of intestinal Crohn's disease. Gastrointest Endosc 30 3 (1984) 167-172
Geboes K., Ectors N., D'Haens G., and Rutgeerts P. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?. Am J Gastroenterol 93 2 (1998) 201-206
Cherian S., and Singh P. Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve. Am J Gastroenterol 99 12 (2004) 2324-2329
Allez M., Lemann M., Bonnet J., Cattan P., Jian R., and Modigliani R. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 97 4 (2002) 947-953
Nahon S., Bouhnik Y., Lavergne-Slove A., Bitoun A., Panis Y., Valleur P., et al. Colonoscopy accurately predicts the anatomical severity of colonic Crohn's disease attacks: correlation with findings from colectomy specimens. Am J Gastroenterol 97 12 (2002) 3102-3107
Carter M.J., Lobo A.J., and Travis S.P. IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl 5 (2004) V1-V16
Horsthuis K., Bipat S., Bennink R.J., and Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 247 1 (2008) 64-79
Horsthuis K., Stokkers P.C., and Stoker J. Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities. Abdom Imaging 33 4 (2008) 407-416
Marshall J.K., Cawdron R., Zealley I., Riddell R.H., Somers S., and Irvine E.J. Prospective comparison of small bowel meal with pneumocolon versus ileo-colonoscopy for the diagnosis of ileal Crohn's disease. Am J Gastroenterol 99 7 (2004) 1321-1329
Tillack C., Seiderer J., Brand S., Göke B., Reiser M.F., Schaefer C., et al. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease. Inflamm Bowel Dis 14 9 (2008) 1219-1228
Louis E., Collard A., Oger A.F., Degroote E., Aboul Nasar El Yagi F.A., and Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49 6 (2001) 777-782
Fraquelli M., Colli A., Casazza G., Paggi S., Colucci A., Massironi S., et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 236 1 (2005) 95-101
Koh D.M., Miao Y., Chinn R.J., Amin Z., Zeegen R., Westaby D., et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 177 6 (2001) 1325-1332
Wold P.B., Fletcher J.G., Johnson C.D., and Sandborn W.J. Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy-feasibility study. Radiology 229 1 (2003) 275-281
Gourtsoyiannis N.C., Grammatikakis J., Papamastorakis G., Koutroumabakis J., Prassopoulos P., Rousomoustakaki M., et al. Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol 16 9 (2006) 1915-1925
Rimola J., Rodriguez S., Garcia-Bosch O., et al. Magnetic resonance for assessment of disease activity and severity in Crohn disease. Gut (2009)
Albert J.G., Martiny F., Krummenerl A., Stock K., Lesske J., Göbel C.M., et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 54 12 (2005) 1721-1727
Sailer J., Peloschek P., Schober E., Schima W., Reinisch W., Vogelsang H., et al. Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease. AJR Am J Roentgenol 185 6 (2005) 1575-1581
Schmidt S., Lepori D., Meuwly J.Y., Duvoisin B., Meuli R., Michetti P., et al. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation. Eur Radiol 13 6 (2003) 1303-1311
Brenner D.J., and Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 357 22 (2007) 2277-2284
Negaard A., Paulsen V., Sandvik L., Berstad A.E., Borthne A., Try K., et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 17 9 (2007) 2294-2301
Biancone L., Calabrese E., Petruzziello C., Onali S., Caruso A., Palmieri G., et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 13 10 (2007) 1256-1265
Martinez M.J., Ripollés T., Paredes J.M., Blanc E., and Marti-Bonmati L. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 34 2 (2009) 141-148
Rapaccini G.L., Pompili M., Orefice R., Covino M., Riccardi L., Cedrone A., et al. Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 39 2 (2004) 188-194
Sans M., Fuster D., Llach J., Lomena F., Bordas J.M., Herranz R., et al. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease. Dig Dis Sci 45 9 (2000) 1828-1835
Ajaj W.M., Lauenstein T.C., Pelster G., Gerken G., Ruehm S.G., Debatin J.F., et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 54 2 (2005) 257-263
Dinter D.J., Chakraborty A., Brade J., Back W., Neff K.W., Singer M.V., et al. Endoscopy and magnetic resonance imaging in patients with Crohn's disease: a retrospective single-centre comparative study. Scand J Gastroenterol 43 2 (2008) 207-216
Langhorst J., Kuhle C.A., Ajaj W., Nüfer M., Barkhausen J., Michalsen A., et al. MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis 13 8 (2007) 1001-1008
Ota Y., Matsui T., Ono H., Uno H., Matake H., Tsuda S., et al. Value of virtual computed tomographic colonography for Crohn's colitis: comparison with endoscopy and barium enema. Abdom Imaging 28 6 (2003) 778-783
Tarjan Z., Zagoni T., Györke T., Mester A., Karlinger K., and Mako E.K. Spiral CT colonography in inflammatory bowel disease. Eur J Radiol 35 3 (2000) 193-198
Bru C., Sans M., Defelitto M.M., Gilabert R., Fuster D., Llach J., et al. Hydrocolonic sonography for evaluating inflammatory bowel disease. AJR Am J Roentgenol 177 1 (2001) 99-105
Voderholzer W.A., Beinhoelzl J., Rogalla P., Murrer S., Schachschal G., Lochs H., et al. Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut 54 3 (2005) 369-373
Seiderer J., Herrmann K., Diepolder H., Schoenberg S.O., Wagner A.C., Göke B., et al. Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small-bowel Crohn's disease: results of a pilot study. Scand J Gastroenterol 42 11 (2007) 1376-1385
Hara A.K., Leighton J.A., Heigh R.I., Sharma V.K., Silva A.C., De Petris G., et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology 238 1 (2006) 128-134
Schreyer A.G., Geissler A., Albrich H., Schölmerich J., Feuerbach S., Rogler G., et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol 2 6 (2004) 491-497
Maccioni F., Bruni A., Viscido A., Colaiacomo M.C., Cocco A., Montesani C., et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238 2 (2006) 517-530
Parente F., Maconi G., Bollani S., Anderloni A., Sampietro G., Cristaldi M., et al. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 50 4 (2002) 490-495
Chiorean M.V., Sandrasegaran K., Saxena R., Maglinte D.D., Nakeeb A., and Johnson C.S. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol 102 11 (2007) 2541-2550
Esteban J.M., Aleixandre A., Hurtado M.J., Maldonado L., Mora F.J., and Nogués E. Contrast-enhanced power Doppler ultrasound in the diagnosis and follow-up of inflammatory abdominal masses in Crohn's disease. Eur J Gastroenterol Hepatol 15 3 (2003) 253-259
Kratzer W., von Tirpitz C., Mason R., Reinshagen M., Adler G., Möller P., et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn's disease. J Ultrasound Med 21 2 (2002) 149-157
Spalinger J., Patriquin H., Miron M.C., Marx G., Herzog D., Dubois J., et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217 3 (2000) 787-791
Masselli G., Casciani E., Polettini E., Lanciotti S., Bertini L., and Gualdi G. Assessment of Crohn's disease in the small bowel: Prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol 16 12 (2006) 2817-2827
Herrmann K.A., Michaely H.J., Seiderer J., Ochsenkuehn T., Reiser M.F., and Schoenberg S.O. The "star-sign" in magnetic resonance enteroclysis: a characteristic finding of internal fistulae in Crohn's disease. Scand J Gastroenterol 41 2 (2006) 239-241
Herrmann K.A., Michaely H.J., Zech C.J., Seiderer J., Reiser M.F., and Schoenberg S.O. Internal fistulas in Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 31 6 (2006) 675-687
Gasche C., Moser G., Turetschek K., Schober E., Moeschi P., and Oberhuber G. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 44 1 (1999) 112-117
Maconi G., Sampietro G.M., Parente F., Pompili G., Russo A., Cristaldi M., et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol 98 7 (2003) 1545-1555
Rutgeerts P., Onette E., Vantrappen G., Geboes K., Broeckaert L., and Talloen L. Crohn's disease of the stomach and duodenum: A clinical study with emphasis on the value of endoscopy and endoscopic biopsies. Endoscopy 12 6 (1980) 288-294
Wagtmans M.J., van Hogezand R.A., Griffioen G., Verspaget H.W., and Lamers C.B. Crohn's disease of the upper gastrointestinal tract. Neth J Med 50 2 (1997) S2-S7
Witte A.M., Veenendaal R.A., van Hogezand R.A., Verspaget H.W., and Lamers C.B. Crohn's disease of the upper gastrointestinal tract: the value of endoscopic examination. Scand J Gastroenterol Suppl 100-5 (1998) 100-105
Chong A.K., Taylor A., Miller A., Hennessy O., Connell W., and Desmond P. Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease. Gastrointest Endosc 61 2 (2005) 255-261
Costamagna G., Shah S.K., Riccioni M.E., Foschia F., Mutignani M., Perri V., et al. A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology 123 4 (2002) 999-1005
Eliakim R., Suissa A., Yassin K., Katz D., and Fischer D. Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn's disease-final report. Dig Liver Dis 36 8 (2004) 519-522
Fireman Z., Mahajna E., Broide E., Shapiro M., Fich L., Sternberg A., et al. Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut 52 3 (2003) 390-392
Golder S.K., Schreyer A.G., Endlicher E., Feuerbach S., Schölmerich J., Kullmann F., et al. Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease. Int J Colorectal Dis 21 2 (2006) 97-104
Mow W.S., Lo S.K., Targan S.R., Dubinsky M.C., Treyzon L., Abreu-Martin M.T., et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2 1 (2004) 31-40
Triester S.L., Leighton J.A., Leontiadis G.I., Gurudu S.R., Fleischer D.E., Hara A.K., et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol 101 5 (2006) 954-964
Hommes D.W., and van Deventer S.J. Endoscopy in inflammatory bowel diseases. Gastroenterology 126 6 (2004) 1561-1573
Leighton J.A., Legnani P., and Seidman E.G. Role of capsule endoscopy in inflammatory bowel disease: where we are and where we are going. Inflamm Bowel Dis 13 3 (2007) 331-337
Bruining D.H., and Loftus Jr. E.V. Crohn's disease clinical issues and treatment: what the radiologist needs to know and what the gastroenterologist wants to know. Abdom Imaging (2008)
Oshitani N., Yukawa T., Yamagami H., Inagawa M., Kamata N., Watanabe K., et al. Evaluation of deep small bowel involvement by double-balloon enteroscopy in Crohn's disease. Am J Gastroenterol 101 7 (2006) 1484-1489
Lescut D., Vanco D., Bonniere P., et al. Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut 34 5 (1993) 647-649
Whelan G., Farmer R.G., Fazio V.W., and Goormastic M. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 88 6 (1985) 1826-1833
Bentley E., Jenkins D., Campbell F., and Warren B. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol 55 (2002) 955-960
Dejaco C., Osterreicher C., Angelberger S., Püspök A., Birner P., Poetzi R., et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy 35 (2003) 1004-1008
Tanaka M., Riddell R.H., Saito H., Soma Y., Hidaka H., Kudo H., et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scan J Gastroenterol 34 (1999) 55-67
Geboes K., Ectors N., D'Haens G., Rutgeerts P., et al. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of IBD. Am J Gastroenterol 93 (1998) 201-206
Jenkins D., Balsitis M., Gallivan S., Dixon M.F., Gilmour H.M., Shepherd N.A., et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 50 (1997) 93-105
Schumacher G., Kollberg B., and Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol 29 (1994) 318-332
Seldenrijk C.A., Morson B.C., Meuwissen S.G.M., Schipper N.W., Lindeman J., Meijer C.J., et al. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 32 (1991) 151420
Theodossi A., Spiegelhalter D.J., Jass J., Firth J., Dixon M., Leader M., et al. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 35 (1994) 961-968
Surawicz C.M. Serial sectioning of a portion of a rectal biopsy detects more focal abnormalities. A prospective study of patients with inflammatory bowel disease. Dig Dis Sci 27 (1982) 434-436
Goldman H. Colonic mucosal biopsy in inflammatory bowel disease. Surgical Pathology 4 (1991) 3-23
Von Herbay A. Evidenz-basierte Leitlinien der DGVS für Diagnostik und Therapie beim Morbus Crohn. Germany Z Gastroenterol 41 (2003) 24-26
Petritsch W., Feichtenschlager T., Gasche C., Hinterleitner T., Judmaier G., Knoflach P., et al. Diagnosis in chronic inflammatory bowel diseases - report of the Austrian Chronic Inflammatory Bowel Disease Study Group. Acta Med Austriaca 25 (1998) 37-43
Hahne M., and Riemann J.F. Inflammatory bowel diseases: diagnosis (including new procedures for small intestine examination). Schweiz Rundsch Med Prax 91 (2002) 2023-2028
Lennard-Jones J.E. Crohn's disease: definition, pathogenesis, aetiology. Clin Gastroenterol suppl I (1980) 173-189 I
Tanaka M., Saito H., Fukuda S., Sasaki Y., Munakata A., Kudo H., et al. Simple mucosal biopsy criteria differentiating among Crohn's disease, ulcerative colitis, and other forms of colitis Measurement of validity. Scand J Gastroenterol 35 (2000) 281-286
Mahadeva U., Martin J.P., Patel N.K., and Price A.B. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology 41 (2002) 50-55
Bernades P., Hecketsweiler P., Benozio M., Descos L., Geffroy Y., Hemet J., et al. Proposition d'un système de critères pour le diagnostic des entérocolite inflammatoires cryptogénétiques (maladie de Crohn et Rectocolite Hémorragique). Gastroentérol Clin Biol 2 (1978) 1047-1054
Jenkins D., Goodall A., and Drew K. What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol 41 (1988) 72-79
Kleer C.G., and Appelman H.D. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 22 (1998) 983-989
Bernstein C.N., Shanahan F., Anton P.A., and Weinstein W.M. Patchiness of mucosal inflammation in treated ulcerative colitis : a prospective study. Gastrointest Endosc 42 (1995) 232-237
Geboes K. Pathology of inflammatory bowel diseases (IBD): variability with time and treatment. Colorectal disease 3 (2001) 2-12
Markowitz J., Kahn E., Grancher K., Hyams J., Treem W., and Daum F. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 88 (1993) 2034-2037
Robert M.E., Tang L., Hao L.M., and Reyes-Mugica M. Patterns of inflammation in mucosal biopsies of ulcerative colitis. Perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol 28 (2004) 183-189
Glickman J.N., Bousvaros A., Farraye F.A., Zholudev A., Friedman S., Wang H.H., et al. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol 28 (2004) 190-197
Tanaka M., and Riddell R.H. The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterol 37 (1990) 18-31
Cook M.G., and Dixon M.F. An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut 14 (1973) 255-262
Ectors N.L., Dixon M.F., Geboes K.J., Rutgeerts P.J., Desmet V.J., and Vantrappen G.R. Granulomatous gastritis : a morphological and diagnostic approach. Histopathology 23 (1993) 55-61
Shapiro J.L., Goldblum J.R., and Petras R.E. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an idiopathic granulomatous gastritis. Am J Surg Pathol 20 (1996) 462-470
Oberhuber G., Puspok A., Oesterreicher C., Novacek G., Zauner C., Burghuber M., et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 112 (1997) 698-706
Wright C.L., and Riddell R.H. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 22 (1998) 383-390
Parente F., Cucino C., Bollani S., Imbesi V., Maconi G., Bonetto S., et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics and diagnostic role. Am J Gastroenterol 95 (2000) 705-711
Levine D., and Reid B. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc 37 (1991) 332-337
Rozen P., Baratz M., Fefer F., and Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 108 (1995) 1361-1370
Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14 (1983) 931-968
Farmer M., Petras R.E., Hunt L.E., Janosky J.E., and Galandiuk S. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol 95 (2000) 3184-3188
Sheehan A.L., Warren B.F., Gear M.W., and Shepherd N.A. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 79 (1992) 955-958
Borley N.R., Mortensen N.J., Jewell D.P., and Warren B.F. The relationship between inflammatory and serosal connective tissue change in ileal Crohn's disease: evidence for a possible causative link. J Pathol 190 (2000) 196-202
Wright R., and Truelove S.C. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis 11 (1964) 847-857
Odze R., Antonioli D., Peppercorn M., and Goldman H. Effect of topical 5-amino-salicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 17 (1993) 869-875
Riley S.A., Mani V., Goodman M.J., Dutt S., and Herd M.E. Microscopic activity in ulcerative colitis: what does it mean?. Gut 32 (1991) 174-178
Bitton A., Peppercorn M.A., Antonioli D.A., Niles J.L., Sha S., Bousvaros A., et al. Clinical, biological and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120 (2001) 13-20
Korelitz B.J., and Sommers S.C. Response to drug therapy in Crohn's disease: Evaluation by rectal biopsy and mucosal cell counts. J Clin Gastroenterol 6 (1984) 123-127
D'Haens G., Geboes K., Ponette E., Pennincks F., and Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 112 (1997) 1475-1481
D'Haens G., Van Deventer S., Van Hogezand R., Chalmers D., Kothe C., Baert F., et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's diseas: a European multicenter trial. Gastroenterology 116 (1999) 1029-1034
Nicholls S., Domizio P., Williams C.B., Dawnay A., Braegger C.P., MacDonald T.T., et al. Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child 71 (1994) 243-247
Beattie R.M., Schiffrin E.J., Donnet-Hughes A., Huggett A.C., Domizio P., MacDonald T.T., et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 8 (1994) 609-615
Breese E.J., Michie C.A., Nicholls S.W., Murch S.H., Williams C.B., Domizio P., et al. Tumor necrosis factor alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106 (1994) 1455-1466
Fell J.M.E., Paintin M., Arnaud-Battandier F., Beattie R.M., Hollis A., Kitching P., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14 (2000) 281-289
Bataille F., Klebl F., Rümmele P., Straub R.H., Wild P., Schölmerich J., et al. Histopathological parameters as predictors for the course of Crohn's disease. Virchows Arch 443 (2003) 501-507
Satsangi J., Silverberg M.S., Vermeire S., and Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55 (2006) 749-753
Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
Louis E., Collard A., Oger A.F., Degroote E., Aboul Nasr El Yafi F.A., and Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49 (2001) 777-782
Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 8 (2002) 244-250
Chow D.K., Leong R.W., Lai L.H., Wong G.L., Leung W.K., Chan F.K., et al. Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis 14 (2008) 536-541
Markowitz J., Grancher K., Kohn N., Lesser M., and Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 119 (2000) 895-902
D'Haens G., Baert F., Van Assche G., Caenepeel P., Vergauwe P., Tuynman H., et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371 (2008) 660-667
Beaugerie L., Seksik P., Nion-Larmurier I., Gendre J.P., and Cosnes J. Predictors of Crohn's disease. Gastroenterology 130 (2006) 650-656
Loly C., Belaiche J., and Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol 43 8 (2008) 948-954
Seksik P., Loftus Jr. E.V., Beaugerie L., et al. Validation of predictors of 5-year disabling CD in a population-based cohort from Olmsted County, Minnesota, 1983-1996. Gastroenterology 132 (2007) A17
Jones J., Loftus Jr. E.V., Panaccione R., Chen L.S., Peterson S., McConnell J., et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 6 (2008) 1218-1224
Rutgeerts P., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 126 (2004) 402-413
Sipponen T., Savilahti E., Kolho K.L., Nuutinen H., Turunen U., and Farkkila M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 14 (2008) 40-46
Sipponen T., Savilahti E., Karkkainen P., Kolho K.L., Nuutinen H., Turunen V., et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease. Inflamm Bowel Dis 14 10 (2008) 1392-1398
Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40 (2008) 955-962
Dubinsky M.C., Kugathasan S., Mei L., Picornell Y., Nebel J., Wrobel I., et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 6 (2008) 1105-1111
Armuzzi A., Ahmad T., Ling K.L., De Silva A., Cullen S., Van Heel, et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 52 (2003) 1133-1139
